ARG58337

anti-ADSL / Adenylosuccinate Lyase antibody

anti-ADSL / Adenylosuccinate Lyase antibody for ICC/IF,Western blot and Human,Mouse,Rat

Overview

Product Description Rabbit Polyclonal antibody recognizes ADSL / Adenylosuccinate Lyase
Tested Reactivity Hu, Ms, Rat
Tested Application ICC/IF, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name ADSL / Adenylosuccinate Lyase
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 1-310 of Human ADSL (NP_000017.1).
Conjugation Un-conjugated
Alternate Names ASASE; ASase; EC 4.3.2.2; Adenylosuccinase; Adenylosuccinate lyase; AMPS; ASL

Application Instructions

Application Suggestion
Tested Application Dilution
ICC/IF1:10 - 1:100
WB1:500 - 1:2000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control Jurkat
Observed Size 47 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 11564 Mouse ADSL

GeneID: 158 Human ADSL

Swiss-port # P30566 Human Adenylosuccinate lyase

Swiss-port # P54822 Mouse Adenylosuccinate lyase

Gene Symbol ADSL
Gene Full Name adenylosuccinate lyase
Background Adenylsuccinate lyase is involved in both de novo synthesis of purines and formation of adenosine monophosphate from inosine monophosphate. It catalyzes two reactions in AMP biosynthesis: the removal of a fumarate from succinylaminoimidazole carboxamide (SAICA) ribotide to give aminoimidazole carboxamide ribotide (AICA) and removal of fumarate from adenylosuccinate to give AMP. Adenylosuccinase deficiency results in succinylpurinemic autism, psychomotor retardation, and , in some cases, growth retardation associated with muscle wasting and epilepsy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Function Catalyzes two non-sequential steps in de novo AMP synthesis: converts (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate (SAICAR) to fumarate plus 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide, and thereby also contributes to de novo IMP synthesis, and converts succinyladenosine monophosphate (SAMP) to AMP and fumarate. [UniProt]
Calculated MW 55 kDa

Images (2) Click the Picture to Zoom In

  • ARG58337 anti-ADSL / Adenylosuccinate Lyase antibody ICC/IF image

    Immunofluorescence: HeLa cells stained with ARG58337 anti-ADSL / Adenylosuccinate Lyase antibody.

  • ARG58337 anti-ADSL / Adenylosuccinate Lyase antibody WB image

    Western blot: 25 µg of Jurkat cell lysate stained with ARG58337 anti-ADSL / Adenylosuccinate Lyase antibody at 1:1000 dilution.